Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells

ABSTRACT Inflammatory response of blood–brain barrier (BBB) endothelial cells plays an important role in pathogenesis of many central nervous system inflammatory diseases, including multiple sclerosis; however, the molecular mechanism mediating BBB endothelial cell inflammatory response remains unclear. In this study, we first observed that knockdown of neuropilin-1 (NRP1), a co-receptor of several structurally diverse ligands, suppressed interferon-γ (IFNγ)-induced C-X-C motif chemokine 10 expression and activation of STAT1 in brain microvascular endothelial cells in a Rac1-dependent manner. Moreover, endothelial-specific NRP1-knockout mice, VECadherin-Cre-ERT2/NRP1flox/flox mice, showed attenuated disease progression during experimental autoimmune encephalomyelitis, a mouse neuroinflammatory disease model. Detailed analysis utilizing histological staining, quantitative PCR, flow cytometry and magnetic resonance imaging demonstrated that deletion of endothelial NRP1 suppressed neuron demyelination, altered lymphocyte infiltration, preserved BBB function and decreased activation of the STAT1–CXCL10 pathway. Furthermore, increased expression of NRP1 was observed in endothelial cells of acute multiple sclerosis lesions. Our data identify a new molecular mechanism of brain microvascular endothelial inflammatory response through NRP1–IFNγ crosstalk that could be a potential target for intervention of endothelial cell dysfunction in neuroinflammatory diseases. Summary: This is the first study to define the role of neuropilin-1, a co-receptor of several structurally distinct cytokines, in the IFNγ-induced inflammatory response of endothelial cells in neuroinflammatory diseases.

[1]  X. Montalban,et al.  Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions , 2015, Multiple sclerosis.

[2]  A. Stahl,et al.  Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk. , 2014, The Journal of clinical investigation.

[3]  D. Pleasure,et al.  Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model , 2014, Journal of Neuroinflammation.

[4]  B. Segal,et al.  Th1‐mediated experimental autoimmune encephalomyelitis is CXCR3 independent , 2013, European journal of immunology.

[5]  H. Kikutani,et al.  Immunological functions of the neuropilins and plexins as receptors for semaphorins , 2013, Nature Reviews Immunology.

[6]  V. Bond,et al.  Pharmacologic Inhibition of CXCL10 in Combination with Anti-malarial Therapy Eliminates Mortality Associated with Murine Model of Cerebral Malaria , 2013, PloS one.

[7]  Aaron J. Johnson,et al.  Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability , 2012, Journal of Neuroinflammation.

[8]  C. Howe,et al.  Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection , 2012, Scientific Reports.

[9]  Jeremy Seto,et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.

[10]  Aaron J. Johnson,et al.  A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption , 2012, Journal of Neuroinflammation.

[11]  M. Cameron.  Primer on Multiple Sclerosis , 2012 .

[12]  C. Lucchinetti,et al.  Meningeal and cortical grey matter pathology in multiple sclerosis , 2012, BMC Neurology.

[13]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[14]  C. Larochelle,et al.  How do immune cells overcome the blood–brain barrier in multiple sclerosis? , 2011, FEBS letters.

[15]  B. Solomon,et al.  Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis , 2011, Proceedings of the National Academy of Sciences.

[16]  D. Mukhopadhyay,et al.  Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. , 2010, The Journal of clinical investigation.

[17]  Aaron J. Johnson,et al.  CD8 T Cell-Initiated Vascular Endothelial Growth Factor Expression Promotes Central Nervous System Vascular Permeability under Neuroinflammatory Conditions , 2009, The Journal of Immunology.

[18]  E. Major,et al.  Progressive multifocal leukoencephalopathy after natalizumab monotherapy. , 2009, The New England journal of medicine.

[19]  T. Lane,et al.  CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination , 2009, Autoimmunity.

[20]  R. Adams,et al.  DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. , 2009, Blood.

[21]  C. Ruhrberg,et al.  Neuropilin 1 signaling guides neural crest cells to coordinate pathway choice with cell specification , 2009, Proceedings of the National Academy of Sciences.

[22]  H. Weiner,et al.  The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? , 2009, Annals of neurology.

[23]  B. Ji,et al.  Robust acinar cell transgene expression of CreErT via BAC recombineering , 2008, Genesis.

[24]  S. Miller,et al.  Astrocytes in multiple sclerosis: A product of their environment , 2008, Cellular and Molecular Life Sciences.

[25]  Christiana Ruhrberg,et al.  Neuropilin 1 and 2 control cranial gangliogenesis and axon guidance through neural crest cells , 2008, Development.

[26]  N. Bouchemal,et al.  Structure–function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex , 2007, Peptides.

[27]  I. Campbell,et al.  CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System1 , 2007, The Journal of Immunology.

[28]  R. Zawatzky,et al.  Anti‐BDCA‐4 (neuropilin‐1) antibody can suppress virus‐induced IFN‐alpha production of plasmacytoid dendritic cells , 2007, Immunology and cell biology.

[29]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[30]  A. Verin,et al.  Neuropilin-1 Regulates Vascular Endothelial Growth Factor–Mediated Endothelial Permeability , 2005, Circulation research.

[31]  R. Henderson,et al.  Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. , 2005, The Journal of endocrinology.

[32]  H. You,et al.  Rac1 Contributes to Maximal Activation of STAT1 and STAT3 in IFN-γ-Stimulated Rat Astrocytes1 , 2004, The Journal of Immunology.

[33]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[34]  Bernd Fritzsch,et al.  Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. , 2003, Developmental cell.

[35]  Olivier Hermine,et al.  A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response , 2002, Nature Immunology.

[36]  H. Hartung,et al.  Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. , 2002, Brain : a journal of neurology.

[37]  T. Yagi,et al.  Requirement of neuropilin 1-mediated Sema3A signals in patterning of the sympathetic nervous system. , 2002, Development.

[38]  S. Kunkel,et al.  EncephalomyelitisDuring Experimental Autoimmune Accumulation in the Central Nervous System T Cell + Control of Encephalitogenic CD4 -Inducible Protein-10) g CXCL10 (IFN-and , 2001 .

[39]  M. Chopp,et al.  Up-Regulation of Neuropilin-1 in Neovasculature after Focal Cerebral Ischemia in the Adult Rat , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  S. Miltenyi,et al.  BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.

[41]  S. Cullheim,et al.  Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration , 2000, The European journal of neuroscience.

[42]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[43]  T. Yagi,et al.  A requirement for neuropilin-1 in embryonic vessel formation. , 1999, Development.

[44]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[45]  C. Koh,et al.  Elevated serum levels of IFN-γ, IL-4 and TNF-α/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage , 1998, Journal of Neuroimmunology.

[46]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[47]  T. Yagi,et al.  Neuropilin–Semaphorin III/D-Mediated Chemorepulsive Signals Play a Crucial Role in Peripheral Nerve Projection in Mice , 1997, Neuron.

[48]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[49]  C. Goodman,et al.  Neuropilin-2, a Novel Member of the Neuropilin Family, Is a High Affinity Receptor for the Semaphorins Sema E and Sema IV but Not Sema III , 1997, Neuron.

[50]  Alex L Kolodkin,et al.  Neuropilin Is a Semaphorin III Receptor , 1997, Cell.

[51]  Moses Rodriguez,et al.  Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody , 1997, Journal of Neuroimmunology.

[52]  R. Fujinami,et al.  Two Models for Multiple Sclerosis: Experimental Allergic Encephalomyelitis and Theiler's Murine Encephalomyelitis Virus , 1996, Journal of neuropathology and experimental neurology.

[53]  L. Eng,et al.  Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells , 1996, Neurochemical Research.

[54]  S. Takagi,et al.  Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. , 1995, Developmental biology.

[55]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[56]  L. Capa,et al.  Differential IL-1 synthesis by astrocytes from Theiler's murine encephalomyelitis virus-susceptible and -resistant strains of mice. , 1993, Cellular immunology.

[57]  K. Agata,et al.  The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors , 1991, Neuron.

[58]  S. Takagi,et al.  An aberrant retinal pathway and visual centers in Xenopus tadpoles share a common cell surface molecule, A5 antigen. , 1989, Developmental biology.

[59]  T. Amagai,et al.  Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies. , 1987, Developmental biology.

[60]  M. Sandberg‐Wollheim,et al.  Longitudinal analysis of three intrathecally produced immunoglobulin subpopulations in an MS patient. , 1985, Journal of immunology.

[61]  L. Scheinberg,et al.  Multiple sclerosis: Circulating antigen‐reactive lymphocytes , 1979, Annals of neurology.

[62]  B. Ryberg.  Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy , 1978, Journal of the Neurological Sciences.

[63]  D. Goodin.  The epidemiology of multiple sclerosis: insights to disease pathogenesis. , 2014, Handbook of clinical neurology.

[64]  H. You,et al.  Rac1 contributes to maximal activation of STAT1 and STAT3 in IFN-gamma-stimulated rat astrocytes. , 2004, Journal of Immunology.

[65]  S. Kunkel,et al.  CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. , 2001, Journal of immunology.

[66]  C. Koh,et al.  Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. , 1998, Journal of neuroimmunology.

[67]  T. Kitsukawa,et al.  Developmentally regulated expression of a cell surface protein, neuropilin, in the mouse nervous system. , 1996, Journal of neurobiology.

[68]  S. Takagi,et al.  Growth-associated expression of a membrane protein, neuropilin, in Xenopus optic nerve fibers. , 1995, Developmental neuroscience.